BORRELLI, ENRICO
 Distribuzione geografica
Continente #
EU - Europa 2.761
NA - Nord America 2.648
AS - Asia 2.102
SA - Sud America 408
Continente sconosciuto - Info sul continente non disponibili 206
AF - Africa 51
OC - Oceania 15
Totale 8.191
Nazione #
US - Stati Uniti d'America 2.470
RU - Federazione Russa 1.540
CN - Cina 740
SG - Singapore 612
IT - Italia 511
BR - Brasile 332
VN - Vietnam 250
SE - Svezia 233
HK - Hong Kong 210
FR - Francia 116
CA - Canada 102
IN - India 80
GB - Regno Unito 78
DE - Germania 75
FI - Finlandia 51
BD - Bangladesh 33
NL - Olanda 33
MX - Messico 32
JP - Giappone 30
PL - Polonia 29
AR - Argentina 25
ES - Italia 24
TR - Turchia 19
ZA - Sudafrica 19
IQ - Iraq 18
KR - Corea 17
ID - Indonesia 16
CO - Colombia 13
IE - Irlanda 12
JM - Giamaica 12
LT - Lituania 12
MY - Malesia 12
AT - Austria 11
NZ - Nuova Zelanda 11
BE - Belgio 10
PY - Paraguay 10
SA - Arabia Saudita 10
EC - Ecuador 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
EG - Egitto 8
MA - Marocco 7
NP - Nepal 7
VE - Venezuela 7
HN - Honduras 6
PK - Pakistan 6
TT - Trinidad e Tobago 6
IL - Israele 5
RO - Romania 5
AU - Australia 4
CL - Cile 4
DZ - Algeria 4
PH - Filippine 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
KE - Kenya 3
PR - Porto Rico 3
UA - Ucraina 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
BS - Bahamas 2
CH - Svizzera 2
CY - Cipro 2
GR - Grecia 2
GT - Guatemala 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
MK - Macedonia 2
PT - Portogallo 2
RS - Serbia 2
SD - Sudan 2
SN - Senegal 2
TJ - Tagikistan 2
AW - Aruba 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
IR - Iran 1
JO - Giordania 1
KZ - Kazakistan 1
MF - Saint Martin 1
NI - Nicaragua 1
PE - Perù 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 7.986
Città #
Ashburn 441
Singapore 362
Moscow 300
San Jose 300
Hong Kong 199
Council Bluffs 168
Beijing 152
Shanghai 132
Dallas 128
New York 125
Milan 105
Ho Chi Minh City 87
Los Angeles 86
Hefei 85
Lauterbourg 74
Hanoi 65
Phoenix 64
Princeton 60
Lawrence 57
Santa Clara 55
São Paulo 36
Helsinki 29
Montreal 27
Orem 26
Chennai 25
Tokyo 25
Toronto 25
Warsaw 25
Brooklyn 24
Atlanta 21
Rome 21
Chicago 19
Boardman 18
London 18
Poplar 18
Houston 17
Johannesburg 16
Naples 16
Denver 15
Mumbai 15
Ludhiana 14
Mexico City 14
Bari 13
Boston 12
Frankfurt am Main 12
Gwanak-gu 12
Novlyanka 12
Nuremberg 12
Omaha 12
Stockholm 12
Turku 11
Amsterdam 10
Ankara 10
Auckland 10
Guangzhou 10
Lappeenranta 10
Manchester 10
Philadelphia 10
Shenzhen 10
Biên Hòa 9
Dublin 9
Hải Dương 9
Kuala Lumpur 9
Munich 9
Rio de Janeiro 9
Seattle 9
The Dalles 9
Brasília 8
Brussels 8
Catania 8
Haiphong 8
Trento 8
Washington 8
Asunción 7
Belo Horizonte 7
Brescia 7
Dhaka 7
Miami 7
Riyadh 7
Turin 7
Vienna 7
Barnet 6
Cesano Boscone 6
Da Nang 6
Hanover 6
Jakarta 6
Kingston 6
Ninh Bình 6
Piracicaba 6
San Francisco 6
San Giovanni la Punta 6
Tianjin 6
Baghdad 5
Bergamo 5
Columbus 5
Curitiba 5
Florence 5
Jacksonville 5
Las Vegas 5
Miano 5
Totale 3.979
Nome #
OCULAR AND GENETIC CHARACTERISTICS OF PATIENTS SURVIVING LONG-LASTING TYPE 1 DIABETES WITHOUT VASCULAR COMPLICATIONS 190
Perifoveal exudative vascular anomalous complex in a highly myopic eye 155
CHOROIDAL VASCULARITY INDEX IN HYDROXYCHLOROQUINE TOXIC RETINOPATHY: A Quantitative Comparative Analysis Using Enhanced Depth Imaging In Spectral Domain Optical Coherence Tomography 147
Peripapillary hyperreflective ovoid mass-like structures (PHOMS) in patients with acute Leber's hereditary optic neuropathy 135
Photoreceptor alteration in intermediate age-related macular degeneration 125
Peripapillary hyperreflective ovoid mass-like structures (PHOMS): OCTA may reveal new findings 125
Choroidal vascularity index in leptochoroid: A comparative analysis between reticular pseudodrusen and high myopia 125
Visual Outcomes and Optical Coherence Tomography Biomarkers of Vision Improvement in Patients With Leber Hereditary Optic Neuropathy Treated With Idebenone 124
Long-term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes with Diabetic Macular Edema treated with Anti-VEGF Therapy 124
Retinal neurodegeneration in age-related macular degeneration 119
Choroidal vascularity index in eyes with central macular atrophy secondary to age-related macular degeneration and Stargardt disease 117
Choriocapillaris flow impairment could predict the enlargement of geographic atrophy lesion 113
Changes in Macular Perfusion After ILUVIEN® Intravitreal Implant for Diabetic Macular Edema: An OCTA Study 111
Choroidal vascularity index in hereditary optic neuropathies 109
CHOROIDAL AMYLOID DEPOSITION: A Multicenter Study of Amyloid Lesions Identified in Late Indocyanine Green Angiography 108
Capturing the Transition From Intermediate to Neovascular AMD: Longitudinal Inner Retinal Thinning and Factors Associated With Neuronal Loss 108
Choroidal vascularity index is associated with geographic atrophy progression 108
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY ASSESSMENT OF THE DIABETIC MACULA: A Comparison Study Among Different Algorithms 107
Longitudinal follow-up and outcome analysis in central serous chorioretinopathy 105
Prevalence and Morphologic Biomarkers of Metamorphopsia in eyes with "Resolved" Chronic Central Serous Chorioretinopathy 104
Imaging biomarkers and clinical factors associated with the rate of progressive inner and outer retinal thinning in patients with diabetic macular edema 103
Spectrally Resolved Fundus Autofluorescence in Healthy Eyes: Repeatability and Topographical Analysis of the Green-Emitting Fluorophores 102
Retinal Thickness Deviation: A New OCT Parameter for Assessing Diabetic Macular Edema 101
In vivo rotational three-dimensional OCTA analysis of microaneurysms in the human diabetic retina 101
Choroidal cleft simulating choroidal caverns in neovascular age-related macular degeneration 101
Choroidal Rift: A New OCT Finding in Eyes with Central Serous Chorioretinopathy 99
Choroideremia: Update On Clinical Features And Emerging Treatments 98
Volume rendered 3D OCTA assessment of macular ischemia in patients with type 1 diabetes and without diabetic retinopathy 97
Choroidal Neovascularization in a Patient with Crohn's Disease 96
Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine 96
Diabetic macular ischemia 94
Deep-learning based automated quantification of critical optical coherence tomography features in neovascular age-related macular degeneration 94
Complications associated with worse visual outcomes in patients with exudative neovascular age-related macular degeneration 93
Impact of COVID-19 on outpatient visits and intravitreal treatments in a referral retina unit: let’s be ready for a plausible “rebound effect” 92
Choroidal luminal and stromal areas and choriocapillaris perfusion are characterised by a non-linear quadratic relation in healthy eyes 92
Dimple in vascularized serous pigment epithelial detachment secondary to neovascular age-related macular degeneration 92
OCT-A characterisation of recurrent type 3 macular neovascularisation 91
Comparison Between Ultra-Widefield Pseudocolor Imaging and Indirect Ophthalmoscopy in the Detection of Peripheral Retinal Lesions 91
INNER AND OUTER CHOROIDAL CHANGES IN THE FELLOW EYE OF PATIENTS WITH UNILATERAL CENTRAL SEROUS CHORIORETINOPATHY 90
Individual vs. combined imaging modalities for diagnosing neovascular central serous chorioretinopathy 90
Gliotic tissue simulating a macular neovascularization in full-thickness macular hole 90
Wolfram Syndrome: Only a Neurodegenerative Disease or Also a Maculopathy? 90
Appearance of cysts and capillary non perfusion areas in diabetic macular edema using two different OCTA devices 89
Short-term outcomes of patients with neovascular exudative AMD: the effect of COVID-19 pandemic 89
Changes in Choroidal Thickness follow the RNFL Changes in Leber’s Hereditary Optic Neuropathy 87
Choroidal thickness and the retinal ganglion cell complex in chronic Leberʼs hereditary optic neuropathy: a prospective study using swept-source optical coherence tomography 86
Multimodal imaging characterization of peripheral drusen 86
Nonexudative Perifoveal Vascular Anomalous Complex: The Subclinical Stage of Perifoveal Exudative Vascular Anomalous Complex? 84
Discerning Between Macular Hemorrhages Due to Macular Neovascularization or Due to Spontaneous Bruch’s Membrane Rupture in High Myopia: A Comparative Analysis Between OCTA and Fluorescein Angiography 84
The retinal neurovascular coupling is impaired in men with vasculogenic erectile dysfunction 82
One-year follow-up of ischemic index changes after intravitreal dexamethasone implant for diabetic macular edema: an ultra-widefield fluorescein angiography study 81
Nonmydriatic widefield retinal imaging with an automatic white LED confocal imaging system compared with dilated ophthalmoscopy in screening for diabetic retinopathy 81
Longitudinal evaluation of the development of wedge-shaped subretinal hyporeflectivity in geographic atrophy 80
Complicated Retinal Pigment Epithelium Humps in High Myopia 80
Spontaneous resolution of optic pit maculopathy: an OCT report 79
Guidelines on Optical Coherence Tomography Angiography Imaging: 2020 Focused Update 79
Multimodal Imaging of Peripapillary hyperreflective ovoid mass-like structures (PHOMS) 78
Rate of misdiagnosis and clinical usefulness of the correct diagnosis in exudative neovascular maculopathy secondary to AMD versus pachychoroid disease 76
Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy 75
Recognition, diagnosis and treatment of chorioretinal folds: Current perspectives 75
Multimodal Imaging Assessment of Vascular and Neurodegenerative Retinal Alterations in Type 1 Diabetic Patients without Fundoscopic Signs of Diabetic Retinopathy 75
Quantitative Analysis of Choriocapillaris Using Swept-Source Optical Coherence Tomography Angiography in Eyes with Angioid Streaks 74
Symptomatic Vitreous Opacities: Exploring the Mismatch between Clinical Observation of Vitreous Alterations and Self-Reported Symptoms 73
TriPla Regimen: A new treatment approach for patients with neovascular age-related macular degeneration in the COVID-19 "era" 73
OCTA characterisation of microvascular retinal alterations in patients with central serous chorioretinopathy 71
Quantification of diabetic macular ischemia using novel three-dimensional optical coherence tomography angiography metrics 71
Choroidal Hyperreflective Foci Represent a Common Finding Across Different Types of Macular Atrophy 70
Emerging therapies in the management of macular edema: A review [version 1; peer review: 2 approved] 70
InCASEOf scoring system for distinction between pachychoroid-associated macular neovascularization and neovascular age-related macular degeneration in patients older than 50 years 69
Predictors of Macular Atrophy after Serous Pigment Epithelial Detachment Collapse in Type 3 Macular Neovascularization and Age-Related Macular Degeneration 68
Impact of bleaching on photoreceptors in different intermediate AMD phenotypes 68
Imaging Biomarkers of Mesopic and Dark-Adapted Macular Functions in Eyes With Treatment-Naïve Mild Diabetic Retinopathy 67
Management of patients with diabetic macular oedema and good visual acuity: new findings from Protocol V 65
Rotational Three-dimensional OCTA: a Notable New Imaging Tool to Characterize Type 3 Macular Neovascularization 65
Neovascular age-related macular degeneration: advancement in retinal imaging builds a bridge between histopathology and clinical findings 64
Morphofunctional analysis of the retina in patients with type 1 diabetes without complications after 30 years of disease 64
Multimodal imaging to detect in vivo responses to aflibercept therapy in a mouse model of type 3 neovascularization 64
Haller’s vessels patterns in non-neovascular age-related macular degeneration 61
Subretinal pseudocysts: A novel OCT finding in diabetic macular edema 60
Management of patients with macular oedema secondary to central retinal vein occlusion: new findings from SCORE2 and LEAVO studies 57
Optical coherence tomography angiography in diabetes: focus on microaneurysms 57
Structural OCT and OCT angiography biomarkers associated with the development and progression of geographic atrophy in AMD 56
Reply to: Non-Exudative Perifoveal Vascular Anomalous Complex: the Subclinical Stage of Perifoveal Exudative Vascular Anomalous Complex? 56
PHOTORECEPTOR OUTER SEGMENT IS EXPANDED IN THE FELLOW EYE OF PATIENTS WITH UNILATERAL CENTRAL SEROUS CHORIORETINOPATHY 55
Taking the right measures to control COVID-19 in ophthalmology: the experience of a tertiary eye care referral center in Italy 54
Optical coherence tomography angiography in diabetes: A review 53
Retinal Telangiectasias Associated with Myelinated Nerve Fibers 52
Structural reorganization of the ophthalmological practice in a COVID-19 hub hospital: experience from European epicenter of the pandemic 51
Deep Learning in Neovascular Age-Related Macular Degeneration 42
OCT risk factors for 2-year foveal involvement in non-treated eyes with extrafoveal geographic atrophy and AMD 37
Visual Performance and Predictive OCT Biomarkers in Epiretinal Membrane Assessment: Beyond Distance Visual Acuity 33
Intersession repeatability of reading performance measures in patients with neovascular age-related macular degeneration 23
Pushing Retinal Imaging Forward: Innovations and their Clinical Meaning. The 2022 Ophthalmologica Lecture 21
Distinct Pathways of Macular Atrophy in Type 3 Macular Neovascularization Associated With AMD 18
Intravitreal faricimab for diabetic macular oedema and neovascular age-related macular degeneration: general considerations and practical recommendations by an expert panel of Italian retina specialists 17
Validation of a deep learning model for automatic detection and quantification of five OCT critical retinal features associated with neovascular age-related macular degeneration 17
Mitochondrial retinopathies and optic neuropathies: The impact of retinal imaging on modern understanding of pathogenesis, diagnosis, and management 17
Ensuring the strict and accurate adherence to inclusion criteria in clinical trials for AMD is crucial 16
Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration 16
The “triple-layer sign”: an optical coherence tomography signature for the detection of non-exudative macular neovascularization 15
Totale 8.078
Categoria #
all - tutte 47.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.048


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202278 0 0 0 35 10 1 9 8 2 0 4 9
2022/2023423 136 95 29 8 1 46 12 22 40 19 4 11
2023/2024550 9 45 46 117 56 120 22 37 7 29 29 33
2024/20251.325 163 67 47 38 103 140 165 123 130 119 92 138
2025/20264.706 325 338 191 538 431 141 469 368 1.306 311 129 159
2026/20271.060 183 302 307 268 0 0 0 0 0 0 0 0
Totale 8.191